Spironolactone Therapy in Chronic Stable Right HF Trial

NCT03344159 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Chronic Right-Sided Heart Failure
Pulmonary Arterial Hypertension
Pulmonary Hypertension, Primary, 2
Pulmonary Hypertension, Primary, 3
Pulmonary Hypertension, Primary, 4
Cardiomyopathy Right Ventricular

Interventions

DRUG: Spironolactone
DRUG: Placebo
RADIATION: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82
DIAGNOSTIC_TEST: Cardiac MRI (Gadolinium enhanced)

Sponsor

Ottawa Heart Institute Research Corporation